Our asthma team are officially the top recruiters fin the world for the GSK Nucala study looking at mepolizumab in severe asthma patients as reported in the nucala study newsletter for September 2017.
Our team of Liz Dark, Janet Oborne, Tina Wilkinson and Charlotte Dobson have achieved not only our original target, but surpassed it.
Well done ladies.